Evelyn Worthington

6PUBLICATIONS
8CO-AUTHORS
Traditional, complementary and integrative medicine not elsewhere classifiedGene and molecular therapyRegenerative medicine (incl. stem cells)Pharmacology and pharmaceutical sciences not elsewhere classifiedPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 05, 2021
Letter in reply.

Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge

|Aug 13, 2021
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses.

Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner

|Feb 23, 2021
Efficacy classification of modern therapies in multiple sclerosis.

Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge

|Oct 22, 2020
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis.

Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge

|Mar 30, 2020
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis.

Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner

|Mar 29, 2020
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis.

Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner

Pageof 1

Frequent Collaborators

6 joint publications

Imtiaz A Samjoo

6 joint publications

Chris Cameron

4 joint publications

Christopher Drudge

4 joint publications

Nicholas Adlard